17 May 2019
Future Science Group launches The Evidence Base at the upcoming ISPOR 2019 Conference
Future Science Group (FSG) has today announced that they will be launching their newest resource, The Evidence Base, at the upcoming ISPOR 2019 Conference. The Evidence Base is a free-to-join, online community to share knowledge, discuss the latest research and continue developments in real-world data and its applications to real-world problems in health care. The site covers hot topics in real-world evidence, health economics and outcomes research (HEOR), comparative effectiveness research, patient-centered decision making and much more.
Real-world evidence has a vital role to play in today’s increasingly strained health care systems. It has never been more important to understand the impact of different treatments on the health of the population and at the individual level, including patient outcomes and cost implications. While evidence from randomized controlled trials (RCTs) will continue to play a vital role in providing data for the approval of new products, the evidence base is now expanding, and trust in real-world data (data obtained outside the traditional RCT framework, from sources including observational research, electronic medical records, disease registries and more) is increasing.
The Evidence Base provides a go-to site to share news and knowledge to help drive this exciting field forwards. Members benefit from the latest news and developments in real-world evidence along with the ability to connect with their peers; paving the way to expand their knowledge and foster future collaboration. In addition, the site provides free access to select peer-reviewed content from FSG’s range of journals, including the Journal of Comparative Effectiveness Research (Medline-indexed, Impact Factor: 1.906 ) along with interviews, conference reports and exclusive commentary from subject experts and thought leaders.
Freya Leask, Publisher of The Evidence Base, explains: “FSG has a wealth of expertise in developing niche scientific content hubs that provide a wide range of educational resources and connect experts in these fields. With this in mind, we have developed The Evidence Base to help the HEOR community stay up-to-date with the latest developments in the expanding field of real-world evidence. I’m looking forward to meeting members of this diverse community at ISPOR to understand their needs and work with them to ensure The Evidence Base is an engaging and meaningful resource in years to come.”
Laura Dormer, Managing Editor of the Journal of Comparative Effectiveness Research, also commented: “We have built up a great relationship with the HEOR community since the launch of the Journal of Comparative Effectiveness Research in 2012. I very much look forward to building on this further via our new partnership with The Evidence Base, which will allow even more interaction and debate on this exciting field of research.”
To register for free access to The Evidence Base, go to: https://www.evidencebaseonline.com/users/sign_up
Freya and Laura will be at ISPOR, along with Joanne Walker, Head of Publishing Solutions. To meet the team please visit booth #211 or contact Freya directly to set up a meeting: email@example.com
About The Evidence Base
The Evidence Base is a community site that unites the diverse community involved in real-world evidence, health economics and outcomes research (HEOR) and decision making. Through partnership with our sister journal, Journal of Comparative Effectiveness Research, we seek to educate and inspire to help this exciting field move forward at an even faster rate. On The Evidence Base, you can find free expert opinion and insight, and exclusive peer-reviewed journal articles, as well as the latest news and advances.
About Future Science Group
Founded in 2001, Future Science Group is a progressive publisher focused on breakthrough medical, biotechnological and scientific research. Future Science Group’s portfolio consists of three publishing imprints, Future Science, Future Medicine, Newlands Press, as well as a content development imprint, PharmaPlatforms. In addition to a core business of subscription and open access journal publishing, Future Science Group develops specialist knowledge networks and content hubs, enabling professionals to easily connect and collaborate with their peers in niche scientific fields.
The aim of Future Science Group is to serve the advancement of clinical practice and drug research by enhancing the efficiency of communication among clinicians, researchers and decision-makers, and by providing innovative solutions to their information needs. This is achieved through a customer-centric approach, use of new technologies, products that deliver value-for-money and uncompromisingly high standards. https://www.future-science-group.com/